NL-OMON53610招募中不适用
Autosomal Dominant Hypocalcemia Types 1 and 2 (ADH1/2) Disease Monitoring Study (DMS) - ADH1DMP
Calcilytix Therapeutics0 个研究点目标入组 2 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Participants from birth to age 90 years must meet all the following criteria
- •for inclusion during screening:
- •1. Have a documented activating variant or variant of uncertain significance of
- •the CASR gene for ADH1 or documented activating variant or variant of uncertain
- •significance of the GNA11 gene for ADH2 associated with a clinical syndrome of
- •hypoparathyroidism prior to enrollment. Note: Acceptable documentation includes
- •CASR or GNA11 genetic analysis report. If no prior documented CASR or GNA11
- •gene variant or variant of uncertain significance, potential participants can
- •undergo CASR and GNA11 gene variant analysis at Screening.
- •2. Be willing and able to provide informed consent or assent after the nature
- •of the study has been explained, and prior to any research-related procedures
- •3. Be willing to provide access to prior medical records including imaging,
- •biochemical, and diagnostic and medical history data, if available
- •4. Be willing and able to comply with the study visit schedule and study
排除标准
- •Participants are excluded from the study if any of the following criteria
- •1. Have serious medical or psychiatric comorbidity that, in the opinion of the
- •Investigator, would present a concern for
- •participant safety or compromise the ability to provide consent or assent,
- •or comply with the study visit schedule and
- •study procedures
- •2. Enrollment in an ADH1/2 interventional clinical study at the time of DMS
- •Screening visit or at any point during the DMS
研究者
相似试验
进行中（未招募）
不适用
ADH1 and ADH2 Disease Monitoring Study (DMS)Autosomal Dominant HypocalcemiaNCT05227287Calcilytix Therapeutics, Inc., a BridgeBio company95
招募中
不适用
Study of clinical profile of afebrile seizures in infantsCTRI/2021/04/033179Dr Karthik C G
已完成
不适用
Familial Hypocalciuric Hypercalcemia: Clinical Aspects and EvolutionFamilial Hypocalciuric HypercalcemiaNCT04872894Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau70
已完成
不适用
Investigation on the management of hypocalcemia induced by citric acid during plasmapheresis/plateletpheresis, through analysis of the serum kinetics of ionized calciumoJPRN-UMIN000037853Japan Red Cross Society36
尚未招募
不适用
Calcium-sensitizing and calcium-desensitizing mechanisms of vascular smooth muscle: Heterogineity of vascular beds and age-related differencesvascular agingDRKS00025021Medizinische Hochschule Brandenburg90